Cutting edge: CD99 is a novel therapeutic target for control of T cell-mediated central nervous system autoimmune disease

Journal of Immunology

Volumn 196, Issue 4, 2016, Pages 1443-1448

  Winger, Ryan C ^a,b   Harp, Christopher T ^a   Chiang, Ming Yi ^a   Sullivan, David P ^a   Watson, Richard L ^a   Weber, Evan W ^a   Podoji, Joseph R ^a   Miller, Stephen D ^a   Muller, William A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD99 ANTIGEN; CD99 PROTEIN, HUMAN; CELL ADHESION MOLECULE; LEUKOCYTE ANTIGEN; MONOCLONAL ANTIBODY;

ANIMAL; ANTAGONISTS AND INHIBITORS; B LYMPHOCYTE; BLOOD BRAIN BARRIER; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ADHESION; CELL MOTION; DENDRITIC CELL; DISEASE MODEL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMAN; IMMUNOLOGY; INFLAMMATION; MOUSE; PHYSIOLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD99; B-LYMPHOCYTES; BLOOD-BRAIN BARRIER; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL ADHESION; CELL ADHESION MOLECULES; CELL MOVEMENT; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; INFLAMMATION; MICE;

EID: 84958582462     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501634     Document Type: Article

References (56)

1. Hickey, W. F. 2001. Basic principles of immunological surveillance of the normal central nervous system. Glia 36: 118-124.
2. Ousman, S. S., and P. Kubes. 2012. Immune surveillance in the central nervous system. Nat. Neurosci. 15: 1096-1101.
3. Frohman, E. M., M. K. Racke, and C. S. Raine. 2006. Multiple sclerosis-The plaque and its pathogenesis. N. Engl. J. Med. 354: 942-955.
4. Lucchinetti, C., W. Bruck, J. Parisi, B. Scheithauer, M. Rodriguez, and H. Lassmann. 2000. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47: 707-717.
5. Ifergan, I., H. Kebir, M. Bernard, K. Wosik, A. Dodelet-Devillers, R. Cayrol, N. Arbour, and A. Prat. 2008. The blood-brain barrier induces differentiation of migrating monocytes into Th17-polarizing dendritic cells. Brain 131: 785-799.
6. Henderson, A. P., M. H. Barnett, J. D. Parratt, and J. W. Prineas. 2009. Multiple sclerosis: distribution of inflammatory cells in newly forming lesions. Ann. Neurol. 66: 739-753.
7. Miller, S. D., E. J. McMahon, B. Schreiner, and S. L. Bailey. 2007. Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis. Ann. N. Y. Acad. Sci. 1103: 179-191.
8. Bailey, S. L., B. Schreiner, E. J. McMahon, and S. D. Miller. 2007. CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ T(H)-17 cells in relapsing EAE. Nat. Immunol. 8: 172-180.
9. Elices, M. J., L. Osborn, Y. Takada, C. Crouse, S. Luhowskyj, M. E. Hemler, and R. R. Lobb. 1990. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 60: 577-584.
10. Siegelman, M. H., D. Stanescu, and P. Estess. 2000. The CD44-initiated pathway of T-cell extravasation uses VLA-4 but not LFA-1 for firm adhesion. J. Clin. Invest. 105: 683-691.
11. Berlin, C., R. F. Bargatze, J. J. Campbell, U. H. von Andrian, M. C. Szabo, S. R. Hasslen, R. D. Nelson, E. L. Berg, S. L. Erlandsen, and E. C. Butcher. 1995. alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 80: 413-422.
12. Chan, J. R., S. J. Hyduk, and M. I. Cybulsky. 2001. Chemoattractants induce a rapid and transient upregulation of monocyte alpha4 integrin affinity for vascular cell adhesion molecule 1 which mediates arrest: an early step in the process of emigration. J. Exp. Med. 193: 1149-1158.
13. Huo, Y., A. Hafezi-Moghadam, and K. Ley. 2000. Role of vascular cell adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesions. Circ. Res. 87: 153-159.
14. Laschinger, M., and B. Engelhardt. 2000. Interaction of alpha4-integrin with VCAM-1 is involved in adhesion of encephalitogenic T cell blasts to brain endothelium but not in their transendothelial migration in vitro. J. Neuroimmunol. 102: 32-43.
15. Jain, P., C. Coisne, G. Enzmann, R. Rottapel, and B. Engelhardt. 2010. Alpha4beta1 integrin mediates the recruitment of immature dendritic cells across the blood-brain barrier during experimental autoimmune encephalomyelitis. J. Immunol. 184: 7196-7206.
16. Vajkoczy, P., M. Laschinger, and B. Engelhardt. 2001. Alpha4-integrin-VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels. J. Clin. Invest. 108: 557-565.
17. Yednock, T. A., C. Cannon, L. C. Fritz, F. Sanchez-Madrid, L. Steinman, and N. Karin. 1992. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 356: 63-66.
18. Baron, J. L., J. A. Madri, N. H. Ruddle, G. Hashim, and C. A. Janeway, Jr. 1993. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177: 57-68.
19. Theien, B. E., C. L. Vanderlugt, T. N. Eagar, C. Nickerson-Nutter, R. Nazareno, V. K. Kuchroo, and S. D. Miller. 2001. Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis. J. Clin. Invest. 107: 995-1006.
20. Lehmann-Horn, K., S. A. Sagan, C. C. Bernard, R. A. Sobel, and S. S. Zamvil. 2015. B-cell very late antigen-4 deficiency reduces leukocyte recruitment and susceptibility to central nervous system autoimmunity. Ann. Neurol. 77: 902-908.
21. Schenkel, A. R., Z. Mamdouh, X. Chen, R. M. Liebman, and W. A. Muller. 2002. CD99 plays a major role in the migration of monocytes through endothelial junctions. Nat. Immunol. 3: 143-150.
22. Lou, O., P. Alcaide, F. W. Luscinskas, and W. A. Muller. 2007. CD99 is a key mediator of the transendothelial migration of neutrophils. J. Immunol. 178: 1136-1143.
23. Winger, R. C., J. E. Koblinski, T. Kanda, R. M. Ransohoff, and W. A. Muller. 2014. Rapid remodeling of tight junctions during paracellular diapedesis in a human model of the blood-brain barrier. J. Immunol. 193: 2427-2437.
24. Watson, R. L., J. Buck, L. R. Levin, R. C. Winger, J. Wang, H. Arase, and W. A. Muller. 2015. Endothelial CD99 signals through soluble adenylyl cyclase and PKA to regulate leukocyte transendothelial migration. J. Exp. Med. 212: 1021-1041.
25. Dufour, E. M., A. Deroche, Y. Bae, and W. A. Muller. 2008. CD99 is essential for leukocyte diapedesis in vivo. Cell Commun. Adhes. 15: 351-363.
26. Bixel, G., S. Kloep, S. Butz, B. Petri, B. Engelhardt, and D. Vestweber. 2004. Mouse CD99 participates in T-cell recruitment into inflamed skin. Blood 104: 3205-3213.
27. Brown, A. M., and D. E. McFarlin. 1981. Relapsing experimental allergic encephalomyelitis in the SJL/J mouse. Lab. Invest. 45: 278-284.
28. Robinson, A. P., C. T. Harp, A. Noronha, and S. D. Miller. 2014. The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment. Handb. Clin. Neurol. 122: 173-189.
29. Ali, J., F. Liao, E. Martens, and W. A. Muller. 1997. Vascular endothelial cadherin (VE-cadherin): cloning and role in endothelial cell-cell adhesion. Microcirculation 4: 267-277.
30. Muller, W. A., C. M. Ratti, S. L. McDonnell, and Z. A. Cohn. 1989. A human endothelial cell-restricted, externally disposed plasmalemmal protein enriched in intercellular junctions. J. Exp. Med. 170: 399-414.
31. Schenkel, A. R., T. W. Chew, and W. A. Muller. 2004. Platelet endothelial cell adhesion molecule deficiency or blockade significantly reduces leukocyte emigration in a majority of mouse strains. J. Immunol. 173: 6403-6408.
32. Mamdouh, Z., A. Mikhailov, and W. A. Muller. 2009. Transcellular migration of leukocytes is mediated by the endothelial lateral border recycling compartment. J. Exp. Med. 206: 2795-2808.
33. Mamdouh, Z., G. E. Kreitzer, and W. A. Muller. 2008. Leukocyte transmigration requires kinesin-mediated microtubule-dependent membrane trafficking from the lateral border recycling compartment. J. Exp. Med. 205: 951-966.
34. Carman, C. V., and T. A. Springer. 2004. A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them. J. Cell Biol. 167: 377-388.
35. McCarthy, D. P., M. H. Richards, and S. D. Miller. 2012. Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virusinduced demyelinating disease. Methods Mol. Biol. 900: 381-401.
36. Weber, E. W., F. Han, M. Tauseef, L. Birnbaumer, D. Mehta, and W. A. Muller. 2015. TRPC6 is the endothelial calcium channel that regulates leukocyte transendothelial migration during the inflammatory response. J. Exp. Med. 212: 1883-1899.
37. Terry, R. L., I. Ifergan, and S. D. Miller. 2016. Experimental Autoimmune Encephalomyelitis in Mice. Methods Mol. Biol. 1304: 145-160.
38. McMahon, E. J., S. L. Bailey, C. V. Castenada, H. Waldner, and S. D. Miller. 2005. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 11: 335-339.
39. Bailey-Bucktrout, S. L., S. C. Caulkins, G. Goings, J. A. Fischer, A. Dzionek, and S. D. Miller. 2008. Cutting edge: central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis. J. Immunol. 180: 6457-6461.
40. Bullard, D. C., X. Hu, T. R. Schoeb, R. G. Collins, A. L. Beaudet, and S. R. Barnum. 2007. Intercellular adhesion molecule-1 expression is required on multiple cell types for the development of experimental autoimmune encephalomyelitis. J. Immunol. 178: 851-857.
41. Cayrol, R., K. Wosik, J. L. Berard, A. Dodelet-Devillers, I. Ifergan, H. Kebir, A. S. Haqqani, K. Kreymborg, S. Krug, R. Moumdjian, et al. 2008. Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nat. Immunol. 9: 137-145.
42. Ifergan, I., H. Kebir, S. Terouz, J. I. Alvarez, M. A. Lécuyer, S. Gendron, L. Bourbonnière, I. R. Dunay, A. Bouthillier, R. Moumdjian, et al. 2011. Role of Ninjurin-1 in the migration of myeloid cells to central nervous system inflammatory lesions. Ann. Neurol. 70: 751-763.
43. Greter, M., F. L. Heppner, M. P. Lemos, B. M. Odermatt, N. Goebels, T. Laufer, R. J. Noelle, and B. Becher. 2005. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 11: 328-334.
44. Chastain, E. M., D. S. Duncan, J. M. Rodgers, and S. D. Miller. 2011. The role of antigen presenting cells in multiple sclerosis. Biochim. Biophys. Acta 1812: 265-274.
45. Clarkson, B. D., A. Walker, M. G. Harris, A. Rayasam, M. Sandor, and Z. Fabry. 2015. CCR2-dependent dendritic cell accumulation in the central nervous system during early effector experimental autoimmune encephalomyelitis is essential for effector T cell restimulation in situ and disease progression. J. Immunol. 194: 531-541.
46. Zozulya, A. L., S. Ortler, J. Lee, C. Weidenfeller, M. Sandor, H. Wiendl, and Z. Fabry. 2009. Intracerebral dendritic cells critically modulate encephalitogenic versus regulatory immune responses in the CNS. J. Neurosci. 29: 140-152.
47. Serafini, B., B. Rosicarelli, R. Magliozzi, E. Stigliano, E. Capello, G. L. Mancardi, and F. Aloisi. 2006. Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells. J. Neuropathol. Exp. Neurol. 65: 124-141.
48. Serafini, B., S. Columba-Cabezas, F. Di Rosa, and F. Aloisi. 2000. Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis. Am. J. Pathol. 157: 1991-2002.
49. Steinman, L. 2014. Immunology of relapse and remission in multiple sclerosis. Annu. Rev. Immunol. 32: 257-281.
50. Muller, W. A. 2007. PECAM: Regulating the start of diapedesis. In Adhesion Molecules: Function and Inhibition. K. Ley, ed. Birkhauser Verlag, Basel, Switzerland, p. 201-220. doi:10.1007/978-3-7643-7975-9-8
51. Sumagin, R., and I. H. Sarelius. 2010. Intercellular adhesion molecule-1 enrichment near tricellular endothelial junctions is preferentially associated with leukocyte transmigration and signals for reorganization of these junctions to accommodate leukocyte passage. J. Immunol. 184: 5242-5252.
52. Hussain, R. Z., L. Hayardeny, P. C. Cravens, F. Yarovinsky, T. N. Eagar, B. Arellano, K. Deason, C. Castro-Rojas, and O. Stuve. 2014. Immune surveillance of the central nervous system in multiple sclerosis-relevance for therapy and experimental models. J. Neuroimmunol. 276: 9-17.
53. Langer-Gould, A., S. W. Atlas, A. J. Green, A. W. Bollen, and D. Pelletier. 2005. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N. Engl. J. Med. 353: 375-381.
54. Stuve, O., C. M. Marra, K. R. Jerome, L. Cook, P. D. Cravens, S. Cepok, E. M. Frohman, J. T. Phillips, G. Arendt, B. Hemmer, et al. 2006. Immune surveillance in multiple sclerosis patients treated with natalizumab. Ann. Neurol. 59: 743-747.
55. del Pilar Martin, M., P. D. Cravens, R. Winger, E. M. Frohman, M. K. Racke, T. N. Eagar, S. S. Zamvil, M. S. Weber, B. Hemmer, N. J. Karandikar, et al. 2008. Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumab. Arch. Neurol. 65: 1596-1603.
56. Calic, Z., C. Cappelen-Smith, S. J. Hodgkinson, A. McDougall, R. Cuganesan, and B. J. Brew. 2015. Treatment of progressive multifocal leukoencephalopathyimmune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after discontinuation of natalizumab. J. Clin. Neurosci. 22: 598-600.